Overview
- 31 inspections across 27 sites are on record.
- 2 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-07-25.
At a glance
Inspections
31
Sites
27
Observations
2
Career since
May 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Raptim Research Pvt. Ltd. | 25 Jul 2025 | Human Drugs | On file |
| SGS Analytics Switzerland AG | 8 Nov 2024 | Human Drugs | |
| Amneal Pharmaceuticals Private Limited | 19 Jul 2024 | Human Drugs | |
| Intas Pharmaceuticals Limited | 12 Jul 2024 | Human Drugs | |
| Invitron Advanced Analytics Private Limited | 10 Nov 2023 | Human Drugs |
Sites inspected
Raptim Research Pvt. Ltd.Navi Mumbai, India1 insp.
SGS Analytics Switzerland AGBirsfelden, Switzerland1 insp.
Amneal Pharmaceuticals Private LimitedMatoda, India1 insp.
Intas Pharmaceuticals LimitedAhmedabad, India1 insp.
Invitron Advanced Analytics Private LimitedHyderabad, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Gajendiran Mahadevan5 shared
Mohsen Rajabi Abhari4 shared
Rochelle B Young4 shared
Li-Hong P Yeh2 shared
Nicola M Fenty-Stewart2 shared
Young M Choi2 shared
Jennifer C Adams2 shared
Melkamu Getie Kebtie1 shared
Courtney N Long1 shared
Kara A Scheibner1 shared
Full investigator report
Get the verbatim findings behind Arindam Dasgupta's 2 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site